APA Alıntı

Cabibbo, G., Celsa, C., Enea, M., Battaglia, S., Rizzo, G. E. M., Busacca, A., . . . Cammà, C. (2020). Progression-Free Survival Early Assessment Is a Robust Surrogate Endpoint of Overall Survival in Immunotherapy Trials of Hepatocellular Carcinoma. Cancers (Basel).

Chicago Stili Alıntı

Cabibbo, Giuseppe, et al. "Progression-Free Survival Early Assessment Is a Robust Surrogate Endpoint of Overall Survival in Immunotherapy Trials of Hepatocellular Carcinoma." Cancers (Basel) 2020.

MLA Alıntı

Cabibbo, Giuseppe, et al. "Progression-Free Survival Early Assessment Is a Robust Surrogate Endpoint of Overall Survival in Immunotherapy Trials of Hepatocellular Carcinoma." Cancers (Basel) 2020.